Oncotarget is a peer-reviewed, open access journal that is published twice weekly. The bio-medical journal initially only published articles based on research on all areas of oncology. It has now become so widely embraced by the health care community that it now offers articles on health topics beyond oncology. Established in 2010, Oncotarget is a production of Impact Journals. This valuable medical resource has as its editors-in-chief noted researchers and educators Mikhail Blagosklonny and Andrei Gudkov. Visit Oncotarget’s profile page at Facebook.
The journal is indexed and abstracted in BIOSIS Previews, Scopus, Science Citation Index Expanded and Index Medicus/PubMed. Between 2011 and 2016, Oncotarget was ranked as one of the top oncology journals annually. It has an Impact Factor of 5.168. Initially published once weekly, Oncotarget has risen so much in impact, quality, volume and importance it is now published on Tuesday and Friday each week. This increase is designed to accelerate the publication’s dissemination of important scientific information. Accepted papers will be released to PubMed directly and quickly in their final paginated permanent form.
The editorial board of Oncotarget includes Nobel Prize winner Andrew V. Schally and former Cancer Research editor-in-chief Carlo M. Croce. Together the men have published more than 37 well-received papers in the journal. According to MEDLINE, Oncotarget plays a major role in sharing papers on important basic science research and has high ethical guidelines and editorial practices making it one of the field of oncology’s most important research journals. It has featured groundbreaking articles by some of the top scientists and researchers in oncology. Learn more at researchgate.net
The newly expanded version of Oncotarget now accepts papers on Cardiology, Cell Biology, Endocrinology, Metabolism, Neuroscience, all areas of Pharmacology and much more. An outstanding journal, Oncotarget publishes more documents on Oncology than any other journal. The publication performs a very useful function for medical professionals and researchers working on cancer research and medicine in general. It receives strong support from the NIH and investigators working in oncology. Printed copies of the online journal are made available to people upon request.
In its 7 years of existence Oncotarget has had a significant impact on cancer research.